IL10 and type 2 diabetes mellitus: Previous genetic studies undertaken in this case-control study from the Tunisian population have assessed the impact of a number of gene variants on T2D risk and vascular complications, such as PPARG [35], eNOS [36], MTHFR [37], IL-10 [38].